Abstract
The anticoagulant factor protein S is a secreted vitamin K-dependent γ-carboxylated protein that is mainly synthesised in the liver but is also made by endothelial cells and megakaryocytes in culture. In previous studies we have shown that protein S acts as a mitogen for cultured human vascular smooth muscle cells. The synthesis and secretion of protein S by endothelial cells suggests that in addition to its role in the coagulation cascade, protein S may be an important autocrine factor implicated in the pathophysiology of the vascular system. The effects of protein S on hVSMC proliferation, migration and survival are discussed. The activation of the components of the MAP kinase pathway, ERK1/2, JNK/SAPK and p38 is also summarised. Binding and chemical cross-linking experiments provided evidence for the existence of a cell surface protein S receptor(s). By virtue of its many cellular effects, it is suggested here that the anticoagulant factor protein S plays an important role in the pathophysiology of the vasculature.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Risau, W. 1997. Mechanisms of angiogenesis. Nature 386: 671–674.
Eisenstein, R, 1991. Angiogenesis in arteries. Pharmacol. Ther. 49: 1–19.
Ross R. 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809.
Kanthou C, Parry G, Wijelath E, Kakkar VV, Demoliou-Mason C. 1992. Thrombininduced proliferation and expression of platelet-derived growth factor-A chain gene in human vascular smooth muscle cells. FEBS Lett. 314: 143–148.
Fukudome K, Esmon CT. 1994. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269: 26486–26491.
Ko FN, Yang YC, Huang SC, Ou JT. 1996. Coagulation factor Xa stimulates plateletderived growth factor release and mitogenesis in cultured vascular smooth muscle cells in rats. J Clin Invest. 98: 1493–1501.
Gordon E, Venkatesan N, Salazar R, Tang H, Schmeidler-Sapiro K, Buckley S, Warburton D, Hall F. 1996. Factor Xll-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 93: 2174–2179.
Rottingen J-A, Enden T, Camerer E, Iversen J-G, Prydz H. 1995. Binding of human factor Vlla to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesise tissue factor. J. Biol. Chem. 270: 4650–4660.
Kanse SM, Benzakour O, Kanthou C, Kost C, Lijnen HR, Preissner KT. 1997. Induction of vascular smooth muscle cell proliferation by urokinse indicates a novel mechanism of action in vasoproliferative disorders. Arterioscler. Throm. Vase. Biol. 17: 2848–2854.
Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T. 1994. Tissue type plasminogen activator is a potent mitogen for humn aortic smooth muscle cells. J. Biol. Chem. 269: 3076–3080.
O’;Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Cao Y, Moses M, Lane WS, Sage EH, Folkman J. 1994. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol 59:471–482.
Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ. 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77–79.
Lee TH, Rhim T, Kim SS. 1998. Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells. J. Biol. Chem. 273:28805–288012
Benzakour O, Formstone C, Rahman S, Kanthou C, Dennehy U, Scully MF, Kakkar VV, Cooper DN. 1995. Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells. Biochem. J. 308:481–485
Newby AC, George SJ. 1996. Proliferation, migration, matrix turnover and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr. Opin. in Cardiol. 11:574–582.
Bennett MR, Evan GI, Schwartz SM. 1995. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95: 2266–2274.
Fukul K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, Ogihara T. 1996. Nitric oxide induces upregulation of fas and apoptosis in vascular smooth muscle. Hypertension 27: 823–826.
Li PF, Dietz R, vonHarsdorf R. 1997. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96:3602–3609.
Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. 1990. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGFloop. Cell 63:515–524.
Raines EW, Dower SK, Ross R. 1989. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243:393–396.
Kanthou C, Benzakour O, Patel G, Deadman J, Kakkar VV, Lupu F. 1995. Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells. Thromb. Haemost. 74: 1340–1347
Mii S, Khalil R, Morgan K, Ware J, Kent K. 1996. Mitogen activated protein kinase and proliferation of human vascular smooth muscle cells. Am. J. Physiol. 270: 142–150.
Godowski PJ, Mark MR, Chen J, Sadick MD, Raab H, Hammonds G. 1995. Reevaluation of the roles of protein S and gas6 as ligands for the receptor tyrosine kinase Rse/ Tyro 3. Cell 82: 355–358
Demer LL, Watson KE, Bostrom K. 1994. Mechanismsy of calcification in atherosclerosis. Trends Cardiovasc Med 4: 45–52.
Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 386:78–81.
Shanahan CM, Proudfoot D, Farzaneh-Far A, Weissberg P. 1998. The role of Gla proteins in vascular calcification. Crit. Rev. Eukaryot. Gene Expr. 8: 2357–2371.
Pierre-Jacques H, Glueck CJ, Mont MA, Hungerford DS. 1997. Familial heterozygous protein-S deficiency in a patient who had mutifocal osteonecrosis. J. Bone Joint. Surg. 79: 1079–1081.
Perez-Mijares R, Payan-Lopez J, Guzman-Zamudio JL, Sanchez-Angulo JI, Gomez-Fernandez P, Ramos-Diaz M, Alcala-Rueda M, Silgado-Rodriguez G, Hermosin-Ramos L, Almaraz-Jimenez M. 1996. Free protein S deficiency in hemodialysis patients due to vascular calcifications? Nephron 74:356–361.
Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ O’Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J. 1999. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 285: 1926–1928.
Dahlbäck B. 1997. Factor V and protein S as cofactors to activated protein C. Haematologic. 82:91–95.
Furie B, Bouchrd BA, Furie BC. 1999. Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid. Blood 93: 798–808.
Mann KG. 1984. Membrane-bound enzyme complexes in blood coagulation. Prog. Hemost. Thromb. 7: 1–23.
Dahlbäck B, Hildebrand B, Malm J. 1990. Chracterisation of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J. Biol. Chem. 265:8127–8135.
Joseph DR. 1997. Sequence and functional relationships between androgen-binding protein/sex hormone-binding globulin and its homologs protein S, Gas6, laminin, and agrin. Steroids 62: 578–588.
Manfioletti G, Brancolini C, Avanzi G, Schneider C. 1993. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol 13:4976–4985.
Nakano T, Higashino K, Kikuchi N, Kishino J, Nomura K, Fujita H, Ohara O, Aritay H. 1995. Vascular smooth muscle cell-derived, Gla-containing growth potentiating factor for Ca2+ mobilising growth factors. J Biol Chem. 270: 5702–5705.
Goruppi S, Ruaro E, Schneider C. 1996. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved N1H3T3 fibroblasts. Oncogene 12:471–480.
Nakano T, Kawamoto K, Higashino K, Arita H. 1996. Prevention of growth arrestinduced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, gas6. FEBSLett. 387: 78–80.
Melaragno MG, Wurhrich DA, Poppa V, Gill D, Lindner V, Berk BC, Corson MA. 1998. Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ. Res. 83: 697–704.
Jamison CS, McDowell SA, Marlar RA, Degen SJ: 1995. Developmental expression of protein C and protein S in the rat. Thromb. Res. 78:407–412.
Fair DS, Marlar RA, Levin EG. 1986. Human endothelial cells synthesize protein S. Blood 67:1168–1172.
Schwarz HP, Heep MJ, Wencel-Drake JS, Griffin JH. 1985. Identification and quantification of protein S in human platelets. Blood 66: 1452–1458.
Maillard C, Berruyer M, Serre CM, Dechavanne M, Delmas PD. 1992. Protein S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 130: 1599–1607.
Stitt TN, Conn G, Gore M, Lai C, Bruno J, Radziejewski C, Mattsson K, Fisher J, Gies DR, Jones PF, Masiakowski P, Ryan TE, Tobkes NJ, Chen DH, DiStefano PS, Long GL, Basilico C, Goldfarb MP, Lemke G, Glass DJ, Yancopoulos GD. 1995. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro3/Axl family of receptor tyrosine kinases. Cell 80: 661–671.
Gasic GP, Arenas CP, Gasic TB, Gasic GJ. 1992. Coagulation factors X, Xa and protein S, as potent mitogens of cultured aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 89: 2317–2324.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kanthou, C., Benzakour, O. (2000). Cellular Effects and Signalling Pathways Activated by the Anti-Coagulant Factor, Protein S, in Vascular Cells. In: Maragoudakis, M.E. (eds) Angiogenesis. Advances in Experimental Medicine and Biology, vol 476. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4221-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4221-6_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6895-3
Online ISBN: 978-1-4615-4221-6
eBook Packages: Springer Book Archive